Previous close | 11.62 |
Open | 11.55 |
Bid | 11.30 x 1300 |
Ask | 11.33 x 800 |
Day's range | 11.26 - 11.75 |
52-week range | 11.26 - 30.27 |
Volume | |
Avg. volume | 458,369 |
Market cap | 417.049M |
Beta (5Y monthly) | 0.89 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.56 |
Earnings date | 07 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 17.47 |
Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the first quarter of 2024 after the market closes on Tuesday, May 7, 2024. The company will also host a conference call beginning at 1:30 p.m. PDT (4:30 p.m. EDT) to discuss its financial results.
Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.